Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myeloma Investment Fund
Norwalk, Connecticut, United Statesmyelomainvestmentfund.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Myeloma Investment Fund is an active venture philanthropy arm of the Multiple Myeloma Research Foundation. It has invested in at least 12 companies pursuing 14 myeloma programs, supporting development from discovery through early clinical trials. The goal is to accelerate transformative therapies for multiple myeloma by providing capital and strategic support to innovative biotech startups and established firms alike. All financial returns are reinvested into the evergreen model for future investments.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyMonoclonal antibodySmall moleculeRNA therapy
- Industry
- Investors
02
Partnerships
Opna BioIndapta TherapeuticsEnvisagenicsNammi TherapeuticsReverb TherapeuticsTRIO Pharmaceuticals
Beyond the preview
Go deeper on Myeloma Investment Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myeloma Investment Fund.